ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 98 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $2,347,674 | +16.6% | 2,898,363 | +0.8% | 0.00% | – |
Q1 2023 | $2,013,734 | -0.2% | 2,876,763 | +0.6% | 0.00% | – |
Q4 2022 | $2,018,488 | -53.0% | 2,859,049 | +1.2% | 0.00% | – |
Q3 2022 | $4,295,000 | +87.7% | 2,825,643 | +22.6% | 0.00% | – |
Q2 2022 | $2,288,000 | +20.4% | 2,304,987 | +74.6% | 0.00% | – |
Q1 2022 | $1,901,000 | -79.8% | 1,320,238 | -26.6% | 0.00% | – |
Q4 2021 | $9,390,000 | -7.1% | 1,798,772 | +3.8% | 0.00% | – |
Q3 2021 | $10,104,000 | -26.1% | 1,732,986 | +2.1% | 0.00% | – |
Q2 2021 | $13,675,000 | +2.1% | 1,696,535 | +5.4% | 0.00% | – |
Q1 2021 | $13,390,000 | +7.1% | 1,609,491 | -2.4% | 0.00% | – |
Q4 2020 | $12,505,000 | -28.4% | 1,649,825 | +0.7% | 0.00% | -100.0% |
Q3 2020 | $17,457,000 | -23.6% | 1,637,719 | +8.7% | 0.00% | 0.0% |
Q2 2020 | $22,842,000 | +92.0% | 1,506,736 | +5.5% | 0.00% | 0.0% |
Q1 2020 | $11,897,000 | -50.5% | 1,428,172 | +0.4% | 0.00% | 0.0% |
Q4 2019 | $24,028,000 | -8.3% | 1,421,811 | +0.7% | 0.00% | 0.0% |
Q3 2019 | $26,215,000 | -17.7% | 1,411,706 | +1.4% | 0.00% | 0.0% |
Q2 2019 | $31,861,000 | +9.3% | 1,392,496 | +0.4% | 0.00% | 0.0% |
Q1 2019 | $29,163,000 | +85.3% | 1,387,455 | +1.4% | 0.00% | 0.0% |
Q4 2018 | $15,737,000 | -46.9% | 1,368,390 | +6.0% | 0.00% | 0.0% |
Q3 2018 | $29,638,000 | +3.8% | 1,291,417 | +0.8% | 0.00% | 0.0% |
Q2 2018 | $28,562,000 | -8.0% | 1,280,816 | -5.8% | 0.00% | 0.0% |
Q1 2018 | $31,059,000 | -11.1% | 1,359,243 | +2.0% | 0.00% | -50.0% |
Q4 2017 | $34,927,000 | +20.7% | 1,333,109 | +3.4% | 0.00% | +100.0% |
Q3 2017 | $28,949,000 | -14.4% | 1,289,479 | +4.2% | 0.00% | -50.0% |
Q2 2017 | $33,837,000 | +20.6% | 1,237,174 | +6.7% | 0.00% | +100.0% |
Q1 2017 | $28,058,000 | +28.6% | 1,159,421 | +10.3% | 0.00% | 0.0% |
Q4 2016 | $21,818,000 | -23.7% | 1,051,444 | +0.2% | 0.00% | -50.0% |
Q3 2016 | $28,603,000 | +81.7% | 1,049,286 | -4.1% | 0.00% | +100.0% |
Q2 2016 | $15,746,000 | +0.9% | 1,094,271 | +0.7% | 0.00% | 0.0% |
Q1 2016 | $15,611,000 | -27.9% | 1,086,346 | +7.9% | 0.00% | 0.0% |
Q4 2015 | $21,643,000 | -93.0% | 1,007,160 | -88.5% | 0.00% | -91.7% |
Q3 2015 | $310,587,000 | +1330.9% | 8,750,824 | +940.5% | 0.01% | +1100.0% |
Q2 2015 | $21,705,000 | +16.8% | 840,993 | +1.8% | 0.00% | 0.0% |
Q1 2015 | $18,581,000 | +21.8% | 825,832 | +3.9% | 0.00% | 0.0% |
Q4 2014 | $15,256,000 | -6.3% | 795,019 | +4.9% | 0.00% | 0.0% |
Q3 2014 | $16,275,000 | +5.3% | 757,693 | +27.5% | 0.00% | 0.0% |
Q2 2014 | $15,452,000 | +23.9% | 594,272 | +3.9% | 0.00% | 0.0% |
Q1 2014 | $12,475,000 | +119.7% | 572,020 | +22.9% | 0.00% | – |
Q4 2013 | $5,678,000 | +8.1% | 465,369 | +18.8% | 0.00% | -100.0% |
Q3 2013 | $5,251,000 | +117.3% | 391,608 | +31.5% | 0.00% | – |
Q2 2013 | $2,417,000 | – | 297,752 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Birchview Capital, LP | 2,067,560 | $53,364,000 | 28.19% |
Selkirk Management LLC | 208,000 | $5,368,000 | 2.94% |
Iguana Healthcare Management, LLC | 270,000 | $6,969,000 | 2.20% |
Opaleye Management Inc. | 100,600 | $2,596,000 | 1.03% |
Miura Global Management | 600,000 | $15,486,000 | 0.94% |
DSC Advisors, L.P. | 57,400 | $1,481,000 | 0.77% |
Cannell & Co. | 1,016,828 | $26,244,000 | 0.74% |
OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 276,549 | $7,138,000 | 0.61% |
Harvest Capital Strategies LLC | 100,000 | $2,581,000 | 0.33% |
Raging Capital Management, LLC | 93,932 | $2,424,000 | 0.31% |